The 5-stage Chester step test assesses aerobic capacity in healthy subjects. It has not been tested in patients with COPD.
OBJECTIVE:
To determine the reliability of the Chester step test in patients with COPD and correlation with pulmonary function test and exercise test results.
METHODS:
Thirty-two patients (mean ± SD FEV1 46 ± 15% of predicted) undertook 2 Chester step tests and two 6-min walk tests, on different days, in random order. A subgroup of 11 patients performed incremental cycle ergometry.
RESULTS:
Thirty-one patients performed stage 1 of the Chester step test. Nineteen patients performed stage 2 of the Chester step test. The number of steps was highly reproducible: 66 ± 41 steps vs 68 ± 41 steps. There was no difference in heart rate or SpO2 between the 2 Chester step tests at the peak of exercise or at the end of each stage. There was a significant correlation between number of steps and FEV1 (r = 0.43, P = .02), and 6-min walk distance (r = 0.60, P = .001). Heart rate increased according to advanced stages of the Chester step test, up to 81 ± 13% of predicted. There was a significant correlation between number of steps and peak heart rate (r = 0.55, P = .001). In the 11 patients who performed the incremental cycling test there was a significant correlation between number of steps and peak work load (r = 0.69, P = .02). In the 6 patients in whom oxygen uptake could be estimated from the Chester step test, oxygen uptake was higher than that measured at the peak of the cycling test (30.8 ± 5.1 mL/kg/min vs 17.4 ± 4.5 mL/kg/min, respectively, P = .001).
CONCLUSIONS:
Despite being highly reproducible, the Chester step test had a very short duration in patients with COPD. The number of steps incremented in each stage seems to be too large for these patients. An adaptation of the Chester step test should be considered for patients with COPD.
HillK, GoldsteinRS. Limited functional performance in chronic obstructive pulmonary disease: nature, causes and measurement. COPD, 2007; 4(3):257–261.
2.
CelliBR, CoteCG, MarinJM, CasanovaC, Montes de OcaM, MendezRA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004; 350(10):1005–1012.
3.
NicolaescuV, RacoveanuC, ManicatideM. Effects of exercise on practocol-treated asthmatic patients. Eur J Clin Pharmacol, 1973; 6(1):3–8.
4.
SwinburnCR, WakefieldJM, JonesPE. Performance, ventilation, oxygen consumption in three different types of exercise test in patients with chronic obstructive pulmonary disease. Thorax, 1985; 40(8):581–586.
5.
Balfour-LynnIM, PrasadSA, LavertyA, WhiteheadBF, DinwiddieR. A step in the right direction: assessing exercise tolerance in cystic fibrosis. Pediatr Pulmonol, 1998; 25(4):278–284.
6.
KramerMR, KrivourkV, LebzelterJ, LianiM, FinkG. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease. Isr Med Assoc J, 1999; 1(3):165–168.
7.
TancrediG, QuattrucciS, ScalercioF, De CastroG, ZicariAM, BonciE, et al. 3-min step test and treadmill exercise for evaluating exercise-induced asthma. Eur Respir J, 2004; 23(4):569–574.
8.
Dal CorsoS, DuarteSR, NederJA, MalagutiC, de FuccioMB, de Castro PereiraCA, NeryLE. A step test to assess exercise-related oxygen dessaturation in interstitial lung disease. Eur Respir J, 2007; 29(2):330–336.
9.
StephanS, de Castro PereiraCA, ColettaEM, FerreiraRG, OttaJS, NeryLE. Oxygen dessaturation during a 4-minute step test: predicting survival in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis, 2007; 24(1):70–76.
10.
RusanovV, ShitritD, FoxB, AmitalA, PeledN, KramerMR. Use of the 15-steps climbing exercise oximetry test in patients with idiopathic pulmonary fibrosis. Respir Med, 2008; 102(7):1080–1088.
11.
ShitritD, RusanovV, PeledN, AmitalA, FuksL, KramerMR. The 15-step oximetry test: a reliable tool to identify candidates for lung transplantation among patients with idiopathic pulmonary fibrosis. J Heart Lung Transplant, 2009; 28(4):328–333.
12.
LauHM, NgGY, JonesAY, LeeEW, SiuEH, HuiDS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother, 2005; 51(4):213–219.
13.
LauHM, LeeEW, WongCN, NgGY, JonesAY, HuiDS. The impact of severe acute respiratory syndrome on the physical profile and quality of life. Arch Phys Med Rehabil, 2005; 86(6):1134–1140.
14.
SykesK. Capacity assessment in the workplace: a new step test. Occup Health, 1995; 47(1):20–22.
15.
RabeKF, HurdS, AnzuetoA, BarnesPJ, BuistSA, CalverleyP, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2007; 176(6):532–555.
16.
PellegrinoR, ViegiG, BrusascoV, CrapoRO, BurgosF, CasaburiR, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005; 26(5):948–968.
17.
PereiraCAC, BarretoSP, SimõesJG. Valores de referência para espirometria em uma amostra da população brasileira adulta. J Pneumol, 1992; 18(1):10–22. Article in Portugese..
18.
World Health Organization. The world health report 2002: reducing risks, promoting health life. Geneva: World Health Organization; 2002..
19.
American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002; 166(1):111–117.
20.
WilsonRC, JonesPW. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci, 1989; 76(3):277–282.
21.
TroostersT, GosselinkR, DecramerM. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999; 14(2):270–274.
SykesK, RobertsA. The Chester step test—a simple yet effective tool for the prediction of aerobic capacity. Physiotherapy, 2004; 90(4):183–188.
24.
NederJA, NeryLE, BagatinE, LucasSR, AnçãoMS, SueDY. Differences between remaining ability and loss of capacity in maximum aerobic impairment. Braz J Med Biol Res, 1998; 31(5):639–646.
25.
KearonMC, SummersE, JonesNL, CampbellEJ, KillianKJ. Effort and dyspnoea during work of varying intensity and duration. Eur Respir J, 1991; 4(8):917–925.
26.
DreherM, WalterspacherS, SonntagF, PrettinS, KabitzHJ, WindischW. Exercise in severe COPD: is walking different from stair-climbing?. Respir med, 2008; 102(6):912–918.
27.
PalangeP, ForteS, OnoratiP, ManfrediF, SerraP, CarloneS. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol, 2000; 88(5):1715–1720.
28.
WijkstraPJ, TenVergertEM, van der MarkTW, PostmaDS, Van AltenaR, KraanJ, KöeterGH. Relation of lung function, maximal inspiratory pressure, dyspnoea and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax, 1994; 49(5):468–472.
29.
MarinJM, CarrizoSJ, GasconM, SanchezA, GallegoB, CelliBR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk-test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001; 163(6):1395–1399.
30.
SteinerMC, SinghSJ, MorganMD. The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil, 2005; 25(1):43–49.
31.
SinghSJ, MorganMD, ScottS, WaltersD, HardmanAE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax, 1992; 47(12):1019–1024.
32.
LuxtonN, AlinsonJA, WuJ, MackeyMG. Relationship between field walking tests and incremental cycle ergometry in COPD. Respirology, 2008; 13(6):856–862.
33.
TurnerSE, EastwoodPR, CecinsN, HillmanD, JenkinsSC. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest, 2004; 126(3):766–773.
34.
DebigaréR, MaltaisF, MalletM, CasaburiR, LeBlancP. Influence of work rate incremental rate on the exercise responses in patients with COPD. Med Sci Sports Exerc, 2000; 32(8):1365–1368.
35.
GläserS, LodziewskiS, KochB, OpitzCF, VölzkeH, EwertR. Influence of the incremental step size in work rate on exercise response and gas exchange in patients with pulmonary hypertension. BMC Pulm Med, 2008; 8(3):1–6.
36.
American Thoracic Society; American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med, 2003; 167(2):211–277.
37.
TroostersT, VilaroJ, RabinovichR, CasasA, BarberàJA, Rodrigues-RoisinR, RocaJ. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J, 2002; 20(3):564–569.
38.
BuckleyJP, SimJ, EstonRG, HessionR, FoxR. Reliability and validity of measures taken during the Chester step test to predict aerobic power and to prescribe aerobic exercise. Br J Sports Med, 2004; 38(2):197–205.
39.
NeryLE, WassermanK, AndrewsJD, HuntsmanDJ, HansenJE, WhippBJ. Ventilatory and gas exchange kinetics during exercise in chronic airways obstruction. J Appl Physiol, 1982; 53(6):1594–1602.
